EJCTS Click here for details of sales representative
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Personal Folders
Right arrow Download to citation manager
Right arrow Author home page(s):
Andrzej Biederman
Right arrow Permission Requests
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Leszek, P.
Right arrow Articles by Trouvé, P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Leszek, P.
Right arrow Articles by Trouvé, P.
Related Collections
Right arrow Cardiac - physiology
Right arrow Molecular biology
Right arrow Valve disease

Eur J Cardiothorac Surg 2006;30:737-743
© 2006 Elsevier Science NL

Reduced myocardial expression of calcium handling protein in patients with severe chronic mitral regurgitation

Przemyslaw Leszeka,*, Jerzy Korewickia, Anna Klisiewicza, Jadwiga Janasa, Andrzej Biedermana, Aldona Browareka, Danièle Charlemagneb, Pascal Trouvéb

a Institute of Cardiology, Alpejska 42 St., 04-628 Warsaw, Poland
b INSERM, Unite 127, Hopital Lariboisiere, 41 boulevard de la Chapelle, 75475 Paris, France

Received 23 January 2006; received in revised form 29 June 2006; accepted 4 July 2006.

* Corresponding author. Address: Heart Failure Department, National Institute of Cardiology, Alpejska 42 St., 04-628 Warsaw, Poland. Tel.: +48 22 34 34 483; fax: +48 22 34 34 522. (Email: leszekp{at}ikard.pl).

Objective: Left ventricle (LV) function was shown to be a principal determinant of morbidity and mortality in both uncorrected and surgically corrected mitral regurgitation (MR). However, the cellular mechanisms that develop in the LV remodeling secondary to volume overload in chronic severe MR is still not well defined. In single ventricular myocyte, a reduced contraction and slowed relaxation have been mainly attributed to defective intracellular Ca2+ currents. Between several Ca2+ handling proteins, sarcoplasmic reticulum Ca2+-ATPase 2 (SERCA2) expression and activity determines not only the extent and rate of relaxation, but also the rate and amplitude of contraction. The aim of the study was to determine whether modifications of SERCA2 gene expression occurs in LV wall remodeling process secondary to chronic severe MR. Methods: The LV samples were obtained from 12 patients presented LV wall remodeling (LV: diastolic/systolic diameter—70 ± 7 mm vs 46 ± 10 mm; diastolic/systolic volume—260 ± 65 ml vs 102 ± 68 ml) due to chronic, severe MR. Expressions of SERCA2 isoforms—SERCA2a and 2b mRNAs were estimated by semiquantitative RT-PCR and normalized to GAPDH. The protein levels of SERCA2 were determined by Western blot after normalization to actin. Results were compared with samples from non-failing human hearts (NFH). Results: On SERCA2 mRNA levels, important reduction on both SERCA isoforms SERCA2a (–40%) and SERCA2b (–49%) compared to NFH, together with significant correlation between isoforms (r = 0.89; p = 0.01) were observed. SERCA2 protein levels were decreased (–38%) in MR compared to NFH. Also significant correlations between SERCA2a/2b and SERCA2 protein expression (r = 0.83, p = 0.017; r = 0.68, p = 0.05, respectively) were observed. Moreover, a negative correlation between protein levels of SERCA2 (r = –0.64, p = 0.053) and left ventricular diastolic diameter was observed. Conclusions: In chronic volume overload the down-regulation of SERCA2a and 2b at the mRNA and SERCA2 protein levels exist. Moreover, protein levels of SERCA2 tend to correlate to the grade of left ventricular diastolic dilatation and suggest an important role LV remodeling.

Abbreviations: ALD = aldosterone • ANGII = angiotensin II • CI = cardiac index • EDD = left ventricle end-diastolic diameter • EDV = left ventricle end-diastolic volume • EF = ejection fraction • ESD = left ventricle end-systolic diameter • ESV = left ventricle end-systolic volume • HF = heart failure • LA = left atrium • LV = left ventricle • MR = mitral regurgitation • NCX = Na+/Ca2+ exchanger • NA = noradrenaline • NFH = non-failing hearts • NYHA = New York Heart Association functional class • PRA = plasma renin activity • PAP = pulmonary artery pressure • PWP = pulmonary wedge pressure • SERCA1, 2, 2a, 2b 3 = Ca2+-ATPase of the sarcoplasmic reticulum—isoforms 1, 2, 2a, 2b, 3 • SR = sarcoplasmic reticulum • SVI = stroke volume index • 2D = two-dimensional transthoracic echocardiography

Key Words: Mitral regurgitation • Left ventricle remodeling • SERCA2 expression




This article has been cited by other articles:


Home page
J. Thorac. Cardiovasc. Surg.Home page
R. M. Suri, H. V. Schaff, J. A. Dearani, T. M. Sundt III, R. C. Daly, C. J. Mullany, M. E. Sarano, and T. A. Orszulak
Determinants of early decline in ejection fraction after surgical correction of mitral regurgitation.
J. Thorac. Cardiovasc. Surg., August 1, 2008; 136(2): 442 - 447.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
ANN THORAC SURG ASIAN CARDIOVASC THORAC ANN EUR J CARDIOTHORAC SURG
J THORAC CARDIOVASC SURG ICVTS ALL CTSNet JOURNALS
Copyright © 2006 European Association for Cardio-Thoracic Surgery. Published by Elsevier. All rights reserved.